Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing HT-0712 With Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

NCT02013310 is registered in ClinicalTrials.gov with Dart NeuroScience, LLC as lead sponsor.

NCT NCT02013310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02013310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing HT-0712 With Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
Lead sponsor
Dart NeuroScience, LLC
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
January 31, 2015
Enrollment
119 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

age-associated memory impairment (aami)